03:19 AM EST, 01/30/2025 (MT Newswires) -- Kevin Charles Gorman, Director, on January 27, 2025, sold 146,105 shares in Neurocrine Biosciences ( NBIX ) for $21,836,503. Following the Form 4 filing with the SEC, Gorman has control over a total of 514,596 shares of the company, with 514,596 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/914475/000091447525000009/xslF345X05/wk-form4_1738195415.xml